Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)

2 May 2018

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunodeficiency and Autoimmune Disorders
Share to Mycobacterium research and diagnosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 29729898
DOI: 10.1016/j.jaci.2018.02.045

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Baricitinib treatment in a patient with a gain-of-function mutation in signal transducer and activator of transcription 1 (STAT1)PMID 29729898Read ↗

STAT1 Gain-of-Function and Hidradenitis Suppurativa Successfully Managed with BaricitinibSemantic proximity Read ↗

A 1-year-old girl with a gain-of-function STAT1 mutation treated with hematopoietic stem cell transplantation.Semantic proximity Read ↗

Life-Saving, Dose-Adjusted, Targeted Therapy in a Patient with a STAT3 Gain-of-Function MutationSemantic proximity Read ↗

Baricitinib treatment in children with COPA syndrome.Semantic proximity Read ↗

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain-of-Function (GOF) Mutations – 10 Children and Review of the LiteratureSemantic proximity Read ↗

Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations—10 Children and Review of the LiteratureSemantic proximity Read ↗

JAK inhibition in early-onset somatic, nonclonal STAT5B gain-of-function diseaseSemantic proximity Read ↗

Three adult cases of STAT1-gain-of-function with chronic mucocutaneous candidiasis treated with JAK inhibitorsSemantic proximity Read ↗

Successful Treatment of Interstitial Lung Disease in STAT3 Gain-of-Function Using JAK InhibitorsSemantic proximity Read ↗

An N-of-1 Trial of Itacitinib for a Patient with Aplastic Anemia Associated with a Gain-of-Function Variant in STAT1Semantic proximity Read ↗

STAT6 gain-of-function disease: p.D519N is a new disease-causing variant that responds well to dupilumab treatmentSemantic proximity Read ↗

Ruxolitinib Induces Interleukin 17 and Ameliorates Chronic Mucocutaneous Candidiasis Caused by STAT1 Gain-of-Function Mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.